SALIX PHARMACEUTICALS LTD Retained Earnings
SALIX PHARMACEUTICALS LTD had Retained Earnings of -$355.48 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2015-03-02
- 2014-12-31: Retained Earnings (Accumulated Deficit) -$355.48M.
- 2014-09-30: Retained Earnings (Accumulated Deficit) -$67.84M; Retained Earnings (Accumulated Deficit) as first filed -$57.53M.
- 2014-06-30: Retained Earnings (Accumulated Deficit) $25.27M; Retained Earnings (Accumulated Deficit) as first filed $31.06M.
- 2014-03-31: Retained Earnings (Accumulated Deficit) $24.85M; Retained Earnings (Accumulated Deficit) as first filed $27.78M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2014-12-31 | -$355.48M 10-K · filed 2015-03-02 | |
| 2014-09-30 | -$67.84M 10-Q/A · filed 2015-03-02 | -$57.53M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $25.27M 10-Q/A · filed 2015-03-02 | $31.06M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $24.85M 10-Q/A · filed 2015-03-02 | $27.78M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $59.43M 10-K · filed 2015-03-02 | $71.65M 10-K · filed 2014-02-28 |
| 2013-09-30 | $19.39M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$27.94M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$48.94M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$71.38M 10-K · filed 2015-03-02 | |
| 2012-09-30 | -$89.00M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$105.54M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$125.67M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | -$135.63M 10-K · filed 2013-03-01 | |
| 2011-09-30 | -$169.22M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$203.50M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | -$222.75M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | -$223.03M 10-K · filed 2012-02-28 |